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Abstract 
Aims: To determine occurrence and recurrence rates of gestational diabetes (GDM) and pre-
existing diabetes mellitus (PDM) among women having at least two consecutive pregnancies and 
to assess risk factors that contribute to GDM recurrence. 
Methods: Population-based study using longitudinally linked hospital discharge and birth 
records (2001-2009) in NSW, Australia.  Participants included women without a pre-existing 
diagnosis of Type 1 or Type II diabetes at time of first pregnancy and with at least a first and 
second birth.  Factors associated with GDM recurrence were examined using multivariate log–
binomial models to adjust for correlation within mothers and estimate relative risks (RR) and 
95% confidence intervals. 
Results:  First occurrence of GDM was 3.7% (5 315/142 843) in the first pregnancy and 2.7% (3 
689/137 528) in the second pregnancy.  The recurrence rate of GDM in a second consecutive 
pregnancy was 41.2%.  Risk of PDM in a pregnancy subsequent to one with first occurrence of 
GDM was 2.2% and 2.0% in the second or third pregnancy, respectively. Among women with a 
GDM diagnosis in the first pregnancy, independent predictors of GDM recurrence were maternal 
age ≥35 years, ethnicity (Middle East/North Africa and Asia), pregnancy hypertension, large for 
gestational age infant and preterm birth in the first pregnancy, longer interpregnancy birth 
interval and pregnancy hypertension and multiple pregnancy in the second pregnancy.   
Conclusions: Women with a first pregnancy complicated by GDM have elevated recurrence 
rates and require screening, active management and monitoring in between and during 
subsequent pregnancies.  
Keywords: diabetes, pregnancy, incidence, recurrence, record linkage 
Abbreviations: Gestational diabetes mellitus (GDM); pre-existing diabetes mellitus (PDM) 
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Introduction 
Gestational diabetes mellitus (GDM) is defined as a carbohydrate intolerance of varying 
degree of severity with an onset or first recognition during pregnancy.1  Some women found to 
have raised glucose levels in pregnancy will have previously undiagnosed type 2 diabetes 
mellitus.1  While estimates vary by country, recent data show that GDM prevalence has 
increased by 10 to 100% in the past 20 years, especially as the uptake of screening has 
increased.2   
The frequency of GDM recurrence is reported to vary from 30 to 84% depending on the 
demographic profile and underlying risk of diabetes in the population, and the diagnostic criteria 
used.3  Previous studies on GDM recurrence have been limited by small sample sizes, single 
study settings (i.e. one obstetric hospital) and from reporting estimates of recurrence for any two 
pregnancies (e.g. 2nd and 4th pregnancies) rather than restricting analysis to consecutive 
pregnancies and to primiparous women.3-5  To our knowledge, there has only been one US study 
that has examined recurrence of GDM using population-based data.4   
Identification of at-risk pregnancies provides a valuable opportunity for early pregnancy 
screening for GDM, monitoring and early intervention strategies.  Discussion over changes in 
screening programs are currently being debated subsequent to the results of a large trial of over 
23,000 women in 10 countries showing continuous associations between maternal glucose 
concentrations and adverse pregnancy outcomes including macrosomia, neonatal hypoglycaemia 
and caesarian section, even at glucose concentrations below those that are usually diagnostic of 
GDM.6  The International Association of Diabetes and Pregnancy Study Group (IADPSG) 
Consensus Panel has proposed a new screening strategy for GDM that involves screening high 
risk women, including those with GDM  in previous pregnancies, early in subsequent 
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pregnancies.7 There is considerable debate around the cost effectiveness of these 
recommendations due to the increased rates of GDM  likely to be detected if this new screening 
programme is implemented.8, 9  In terms of early intervention strategies, The Australian 
Carbohydrate Intolerance Study in Pregnant Women (ACHOIS) found that treatment of women 
with impaired glucose tolerance in pregnancy reduced adverse perinatal outcomes defined as 
death, shoulder dystocia, bone fracture, and nerve palsy10 and a large trial by Landon and 
colleagues found that treatment for impaired glucose tolerance (‘mild gestational diabetes’) 
reduced the risks of fetal overgrowth, shoulder dystocia, caesarean delivery, and hypertensive 
disorders.11  
The aim of the present study was to determine the occurrence and recurrence rates of 
GDM and PDM among women having at least two consecutive pregnancies and to assess risk 
factors for GDM recurrence. 
Methods 
The study population included all women with at least first and second births in New 
South Wales (NSW) between 1 Jan. 2001 to 31 Dec. 2009 (n=479, 068).  NSW is the most 
populous state in Australia (~7.1 million), and has over one third of all Australian births (~90 
000 births per annum).12   Exclusions included women with a first birth prior to 1 Jan. 2001, with 
only one pregnancy during the study period, with non-consecutive pregnancies (e.g. an 
intervening birth occurred outside of NSW), with missing parity for any pregnancy (0.09% of 
excluded observations) or with a diagnosis of PDM (Type 1 or Type 2) at their first pregnancy.  
Population health data were obtained from two validated NSW Ministry of Health 
computerised data sets: the Perinatal Data Collection (PDC) and the Admitted Patients Data 
Collection (APDC). The PDC (referred to as ‘birth data’) is a statutory population-based 
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surveillance system that includes information on all births at ≥20 weeks of gestation or 
birthweight at least 400 g. Information on maternal characteristics, pregnancy, labour and 
delivery, and infant outcomes are reported by the attending midwife or doctor. The APDC 
(referred to as ‘hospital data’) is a census of all NSW inpatient hospital discharges (public and 
private).  In our dataset, diagnoses and procedures for each hospitalisation were recorded from 
the medical records and coded according to the International Classification of Diseases, 10th 
revision, Australian Modification (ICD-10-AM) and the affiliated Australian Classification of 
Health Interventions (ACHI). 
Record linkage for the study was undertaken by an independent body, the NSW Centre 
for Health Record Linkage (CHeReL), in accordance with NSW privacy guidelines. Probabilistic 
record linkage methods were used to link birth and hospital data for each woman providing 
longitudinal information on the pregnancy history.  Birth and hospital discharge data was 
available for a woman’s first and subsequent pregnancies (i.e. 2nd, 3rd, 4th, etc).    Only de-
identified data were available to the researchers.  The study was approved by the NSW 
Population and Health Services Research Ethics Committee.  
The primary outcome of interest was GDM, including progression to pre-existing (Type 
2) diabetes (PDM) in a subsequent pregnancy. Each record was searched in up to 20 ICD 
diagnosis fields for a GDM diagnosis code (O24.4, O24.9) or for a PDM diagnosis code (E11, 
E13, E14, O24.0-O24.3).  Diabetes (GDM and PDM) was identified from the hospital data.  
Validation studies of the hospital data indicate 69%-96% ascertainment of GDM with few false 
positives, and 100% ascertainment of PDM with no false positives.13, 14  These sensitivity and 
specificity values are in keeping with those reported by other international validation studies of 
birth and hospital records for identification of GDM and PDM.15   
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 Maternal, pregnancy and obstetric risk factors that are well and accurately reported in 
birth and/or hospital data were included in the analysis.16, 17  Explanatory variables measured 
during the first and second pregnancy included maternal age, mother’s country of birth, multiple 
pregnancy, smoking during pregnancy, hypertension in pregnancy (including chronic, 
gestational, and preeclampsia), large for gestational age (>90th percentile birthweight for 
gestational age and sex), preterm birth (<37 weeks gestation), locality (urban versus rural) and 
type of hospital care (public versus private).  The interpregnancy interval was calculated as the 
time between the dates of two consecutive live births minus the second infant’s gestational age. 
Statistical analyses 
Using contingency table analysis, occurrence and recurrence rates of GDM and PDM 
were calculated for first, second and third pregnancies. For multivariate risk factor analyses, log–
binomial models using generalized estimating equations (GEE) were used to adjust for 
correlation within mothers and estimate relative risks (RR) and 95% confidence intervals.  In 
adjusted models, explanatory factors included the following first pregnancy factors: maternal 
age, maternal country of birth, pregnancy hypertension, large for gestational age infant, preterm 
birth, and the following second pregnancy factors: interpregnancy interval, smoking during 
pregnancy, pregnancy hypertension and multiple pregnancies.    
Selection of first and/or second pregnancy factors to include in the model were based on 
whether the risk factor was time constant (i.e. country of birth), collinear with other variables 
(i.e. maternal age in first pregnancy and interpregnancy interval in second pregnancy) and 
whether the risk factor was identifiable during the second pregnancy (i.e. pregnancy outcomes 
such as preterm birth and infant size from the first pregnancy would be known; however, in a 
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second pregnancy only multiple birth would be known during antenatal care and GDM 
screening).  
Adjusted relative risks were only calculated for the risk of recurrence in a second 
pregnancy, and not for a third pregnancy, given the small event rate and the number of 
adjustment factors.  To determine whether timing of GDM screening during pregnancy had any 
impact on the association between risk factors and GDM recurrence, multivariate analysis was 
also performed restricting the analysis to women with infants born >28 weeks gestation. During 
the study period in NSW, guidelines recommended that women be screened at 26–28 weeks’ 
gestation using a non-fasting 50-g glucose challenge test screening.18  All analyses were carried 
out using SAS 9.1 (SAS Institute, Cary, NC, USA).  
Results 
During the study period, there were 142,843 women with two consecutive births in NSW, 
of whom 20.1% (n= 28,724) had a third pregnancy.  Study characteristics of women by GDM 
status in the first pregnancy are presented in Table 1. Compared to first pregnancies without 
GDM, women with GDM in their first pregnancy were more likely to be ≥35 years of age, to be 
born in countries in the Oceania or Pacific Islands, Middle East or North Africa, or Asia, to have 
gestational hypertension or preeclampsia, to have a multiple pregnancy and to live in an urban 
area (Table 1).   
The 142,843 women in the study population had 318, 447 pregnancies and 3.9% of these 
were complicated by GDM.  The first occurrence of a GDM diagnosis in the first, second and 
third pregnancy was 3.7%, 2.7% and 2.1%, respectively (Figure 1).  Overall, the rate of GDM at 
the first, second and third pregnancy was 3.7%, 4.1% and 3.7%, respectively.  For the 5,315 
(3.7%) women with GDM in their first pregnancy, the recurrence risk for a second pregnancy 
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with GDM was 41.2% (adjusted RR: 21.33: 95% CI: 19.90, 22.86).  The recurrence rate of GDM 
in a third consecutive pregnancy (after two previous GDMs) was 60.1%.  Women with an 
intervening pregnancy with no GDM reported (i.e. GDM in the first and third pregnancies only) 
had a 22.9% rate of GDM in the third pregnancy.  The risk of PDM in a pregnancy subsequent to 
one with first occurrence of GDM was similar whether the GDM was in the second or third 
pregnancy, 2.2% and 2.0% respectively. All women with PDM in a second pregnancy also had 
the diagnosis recorded in their third pregnancy.  
Among women with first birth GDM, risk factors for recurrence of GDM (i.e. GDM in 
the first and second pregnancies) included the following first pregnancy factors: older maternal 
age ( ≥35 years), maternal country of birth (Middle East/North Africa and Asia), large for 
gestational age infant and preterm birth; and second pregnancy factors: increasing 
interpregnancy birth interval, pregnancy hypertension, and multiple pregnancy (Table 2).  
Results of the sensitivity analysis which excluded women with infants born ≤28 weeks of 
gestation for either the first or second pregnancy (n=28 cases excluded) found no notable 
difference in the multivariate results for predictors of GDM recurrence (results not shown). 
Discussion 
 In this population-based prospective cohort study, we found that first diagnosis of GDM 
was highest in the first pregnancy (3.7%) compared to subsequent pregnancies (2.7% and 2.1% 
in the second and third pregnancy, respectively) and that women with GDM in their first 
pregnancy are at higher risk of GDM in their subsequent pregnancies.  Forty-one percent of 
women with a GDM diagnosis in their first pregnancy had GDM recurrence in their second 
consecutive pregnancy.  The risk of GDM recurrence decreased, but was not ameliorated, after 
an intervening non-GDM pregnancy.  Risk factors for recurrent GDM included the following 
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first pregnancy factors: older maternal age, Middle Eastern, North African and Asian country of 
birth, large for gestational age infant, and preterm birth; and second pregnancy factors: 
increasing interpregnancy birth interval, pregnancy hypertension, and multiple pregnancy. 
 A comparison of GDM recurrence rates found in this study to those in the literature is 
hampered by the fact that most of the previous studies on GDM recurrence report estimates of 
GDM in any recorded subsequent pregnancy that occurred after an index pregnancy, rather than 
restricting their analysis to first, second and third consecutive pregnancies.3-5, 19, 20  However, a 
study among Kaiser Permanente in California of women with two consecutive singleton births 
reported rates remarkably similar to those found in our study.4  The rate of GDM recurrence in 
the second pregnancy among women with GDM in the first pregnancy was 41.3% compared to 
41.2% in our study, the recurrence rate of GDM in a third consecutive pregnancy (after two 
previous GDMs) was 56.9% in the Getahun et al. study compared to 60.1% in our study, and the 
rate of GDM recurrence in a third pregnancy after an intervening unaffected pregnancy was 
23.4% compared to 22.9% in our study.4 
The risk patterns for occurrence and recurrence of GDM observed in the present study are 
similar to recurrence studies on other pregnancy conditions, such as postpartum haemorrhage 
and breech presentation.21, 22 Common patterns observed include: highest risk of occurrence in 
the first pregnancy, increased risk with each subsequent pregnancy and decreased risk after an 
intervening unaffected pregnancy.  The rate of recurrence of GDM in this study (41.2%) is much 
higher than recurrence rates for other pregnancy complications, including  postpartum 
haemorrhage (14.8%),21  placenta praevia (4.3%),23  and pre-eclampsia (ranges from 6.8% to 
65% depending on severity and complications of the initial case).24  Thus, GDM in a previous 
pregnancy is a strong indicator of future risk and useful clinical marker for identifying women at 
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elevated risk. Strategies to improve early detection of recurrent GDM include increasing 
education to healthcare providers about the importance of collecting detailed pregnancy history 
information, following screening guidelines that include early screening or diagnostic tests for 
GDM, and putting systems in place that will ensure comprehensive medical information from a 
woman’s previous pregnancy is collected, accessible and referred to, so that it can factored into 
antenatal care during future pregnancies.   
In terms of GDM recurrence, information on first pregnancy (i.e. maternal age, ethnicity, 
pregnancy hypertension) and second pregnancy (i.e. previous large for gestational age infant, 
previous preterm birth, multiple pregnancy) risk factors that were identified in the present study 
are readily available and already ascertained as part of routine antenatal care.  While many of the 
identified risk factors have previously been associated with increased risk of diabetes in 
general,25, 26 pregnancy hypertension in the first and second pregnancy, previous preterm birth 
and long interpregnancy birth interval have not been identified in previous GDM recurrence 
studies.   Studies on Type 2 diabetes have reported an increased prevalence of hypertension; 
hypertension being twice as common in individuals with diabetes as compared to those without 
diabetes.27   Co-morbidity may also be related to unhealthy lifestyle factors such as obesity, poor 
diet and lack of exercise.  Risk factors that were identified in this study which support findings 
from previous recurrence studies include ethnicity, older maternal age, and infant birth weight in 
the prior pregnancy.4, 5, 28   Factors identified in other recurrence studies that were not available 
for analysis in this study are body mass index, and insulin requirement in the first pregnancy.5, 28  
The clinical and policy implications of these study findings indicate that the high rate of 
GDM recurrence makes prevention and screening in this high-risk group an obvious part of 
antenatal care.  All women with a previous history of GDM  should have a follow-up glucose 
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tolerance test after the pregnancy, be counselled on healthy lifestyle behaviours, preferably prior 
to pregnancy, and be tested for GDM in any subsequent pregnancies. These findings also 
reinforce the importance of identifying GDM in first-time mothers.  Women not appropriately 
screened, diagnosed and classified for GDM in their first pregnancy will not be identified as 
high-risk for diabetes screening in the postpartum period or in subsequent pregnancies.   Well-
recognized risk factors for GDM include increased body mass index, advanced maternal age, a 
family history of type 2 diabetes, certain ethnicities including Asian, Hispanic, and Native 
American, polycystic ovary disease, previous stillbirth, high blood pressure during pregnancy, 
and multiple pregnancies.29 The risk factors for GDM occurrence found in the present study 
correlate with previous studies29 and the clinical risk assessment criteria  (such as age, ethnicity 
and family history) that is already part of recommendations for identifying high-risk women for 
earlier and more extensive blood glucose screening and testing.7  
 Importantly, in this study, women in rural areas were less likely to have a GDM diagnosis 
in the first pregnancy compared to women in urban localities.  This finding may reflect 
differences  in population risk profiles in urban and rural communities in terms of adiposity, 
ethnicity, or lifestyle behaviours such as diet and exercise.  Another possibility is that women in 
rural areas have more limited access to health care  and medical resources compared to women in 
urban areas and may not be screened for or diagnosed with GDM during their pregnancy.  The 
generalisability of this finding to other countries is uncertain, but it is likely a similar situation in 
countries with large land masses and low-population density, such as Canada and the United 
States or in countries where large proportions of population live in rural areas, such as India and 
China.   Further research examining barriers in rural communities to diabetes screening, patient 
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access to healthcare services and education are needed to improve detection and ensure adequate 
management once cases are identified.  
 The strengths of our study include a large sample size, inclusion of several clinically 
relevant and easily identifiable risk factors, use of validated risk factors and outcomes, limiting 
the analysis to nulliparous women and longitudinally linked population-based data, which 
allowed us to follow the consecutive pregnancies of individual women.  Interpretation of study 
findings should however be made in the context of study limitations.  There has been a reported 
increase in GDM screening from the beginning to the middle of the 1990s30 therefore, estimates 
of GDM occurrence may be affected by increased screening activity. To reduce the introduction 
of ascertainment bias, the study period was limited to recent years and recurrence rates were 
analysed for women who were all diagnosed with GDM in their first pregnancy.  Since, women 
in childbearing age are usually not screened for diabetes pre-pregnancy, it is difficult to 
distinguish between undiagnosed diabetes existing before pregnancy and hyperglycemia induced 
by pregnancy.2   It is also possible that some women with GDM may have actually had 
undiagnosed PDM and that the recurrence rate of GDM may also incorporate some cases of 
PDM among women that were not tested for diabetes in between pregnancies.  A limitation of 
using already existing population health databases is the lack of information on certain factors of 
interest.  In this study, there was no information on maternal prepregnancy weight and weight 
gain during pregnancy or on postpartum lifestyle changes after a GDM pregnancy or diabetes 
treatments during pregnancy such as diet and insulin, which may reflect disease severity.   
In conclusion, results of this study reveal that women are more likely to have GDM if 
they had GDM in a previous (immediately before) or prior (non-consecutive) pregnancy.  Based 
on these findings, we recommend that health professionals be aware of the increased risk of 
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GDM in subsequent pregnancies and the risk factors that increase risk of recurrence so that they 
can counsel and manage high-risk patients accordingly.   
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Table 1  
Descriptive characteristics of women with and without a first pregnancy diagnosis of 
gestational diabetes (GDM) from Jan 2001 to Dec 2009, NSW. 
 
 
 
 
First birth, n (%)  
p-value GDM  
n= 5, 315 (3.7) 
No GDM  
n= 137, 528 (96.3) 
Maternal age 
 <25 years 
 25-34 years 
 ≥35 years 
 
740 (13.9) 
3731 (70.2) 
844 (15.9) 
 
38894 (28.3) 
87000 (63.3) 
11634 (8.5) 
 
<0.0001 
Reference 
<0.0001 
 
Country of birth 
 Australia & New Zealand 
 Oceania/Pacific Islands 
 Middle East/North Africa 
 Asia 
 Others (Europe, NA, etc) 
 
 
3059 (58.9) 
119 (2.3) 
268 (5.2) 
1313 (25.3) 
436 (8.4) 
 
 
103221 (77.4) 
1471 (1.1) 
4520 (3.4) 
13196 (9.9) 
10916 (8.2) 
 
 
Reference 
<0.0001 
<0.0001 
<0.0001 
<0.0001 
 
Smoking during pregnancy 
 
436 (8.2) 
 
17361 (12.6) 
 
<0.0001 
 
Pregnancy hypertension1  
 
781 (14.7) 
 
14922 (10.9) 
 
<0.0001 
 
Multiple pregnancy 
 
57 (1.1) 
 
959 (0.7) 
 
0.001 
 
Urban residence (versus rural) 
 
4200 (79.0) 
 
97796 (71.1) 
 
<0.0001 
 
Public hospital (versus private) 
 
1454 (27.4) 
 
38525 (28.0) 
 
0.30 
1Includes gestational hypertension and preeclampsia.
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Table 2 
Risk of developing gestational diabetes in second consecutive pregnancy among women with a first pregnancy diagnosis of gestational diabetes 
from Jan 2001 to Dec 2009, NSW. 
 Second birth, n (%)  
Crude RR 
(95% CI) 
 
p-value 
 
Adjusted RR  
(95% CI) 
 
p-value  GDM 
n=2192 (42.2) 
No GDM 
n=3005(57.8) 
1st pregnancy factors       
Maternal age 
 <25 years 
 25-34 years 
 ≥35 years 
 
269 (12.3) 
1541 (70.3) 
382 (17.4) 
 
448 (14.9) 
2111 (70.3) 
446 (14.8) 
 
0.82 (0.70, 0.97) 
Reference 
1.17 (1.01, 1.37) 
 
0.02 
-- 
0.04 
 
0.87 (0.73, 1.03) 
Reference 
1.19 (1.02, 1.39) 
 
0.10 
-- 
0.03 
Country of birth 
 Australia & New Zealand 
 Oceania/Pacific Islands 
 Middle East/North Africa 
 Asia 
 Others (Europe, NA, etc) 
 
1151 (53.7) 
49 (2.3) 
122 (5.7) 
652 (30.4) 
170 (7.9) 
 
1840 (62.7) 
62 (2.1) 
140 (4.8) 
633 (21.6) 
262 (8.9) 
 
Reference 
1.26 (0.86, 1.85) 
1.39 (1.08, 1.80) 
1.65 (1.44, 1.88) 
1.04 (0.84, 1.28) 
 
 
0.23 
0.01 
<0.0001 
0.73 
 
Reference 
1.25 (0.84, 1.84) 
1.44 (1.11, 1.86) 
1.71 (1.49, 1.96) 
1.01 (0.82, 1.24) 
 
-- 
0.27 
0.006 
<0.0001 
0.94 
Pregnancy hypertension1 350 (16.0) 404 (13.4) 1.22 (1.05, 1.43) 0.01 1.16 (0.98, 1.38) 0.08 
LGA 90th percentile 457 (20.9) 523 (17.4) 1.25 (1.09, 1.44) 0.002 1.36 (1.17, 1.57) <0.0001 
Preterm birth (<37 weeks) 198 (9.0) 210 (7.0) 1.32 (1.08, 1.62) 0.007 1.23 (1.00, 1.51) 0.06 
2nd pregnancy factors       
Interpregnancy interval in years, mean (±SD) 2.48 (1.20) 2.35 (1.09) 1.11 (1.05, 1.16) <0.0001 1.09 (1.03, 1.14) 0.001 
Smoking during pregnancy 142 (6.5) 251 (8.4) 0.76 (0.61, 0.94) 0.01 0.92 (0.74, 1.16) 0.48 
Pregnancy hypertension1 239 (10.9) 239 (8.0) 1.42 (1.17, 1.71) 0.0003 1.34 (1.09, 1.65) 0.006 
Multiple pregnancy 47 (2.1) 30 (1.00) 2.17 (1.37, 3.45) 0.001 2.13 (1.34, 3.38) 0.001 
1Includes gestational hypertension and preeclampsia. 
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Figure 1 
 
Title: Occurrence and recurrence for gestational diabetes (GDM) and pre-existing diabetes (PDM) 
among women in the period 2001–2009 in New South Wales. 
 
 
 
 
